| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260949.1 |
Ponatinib |
Sarcoma |
0.028132075 |
Resistant |
| ENSG00000260949.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033810164 |
Resistant |
| ENSG00000260949.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.029454861 |
Sensitive |
